DNA Electronics


DNAe develops a cartridge-based, semiconductor (microchip) sequencing platform designed for rapid, direct-from-specimen genomic analysis at or near the point of care. The company focuses on infectious disease (bloodstream infection and antimicrobial resistance) and is expanding applications into viral detection and oncology (liquid biopsy/ctDNA). DNAe reports a fully automated, sample-to-report workflow and engages with clinical partners through early access programs and trials.

Industries

biotechnology

Nr. of Employees

medium (51-250)

DNA Electronics

London, England, United Kingdom, Europe


Products

LiDia-SEQ platform

A cartridge-based, automated sample-to-report sequencing platform that performs direct-from-specimen genomic analysis on a semiconductor microchip and produces identified pathogens, resistance markers or genomic findings for clinical use (development-stage).


Services

Early Access Program (EAP) for clinical partners

Collaborative program providing early access to assays and prototype systems: Phase One offers sample testing (whole blood and isolates) performed by the company for research use; Phase Two plans placement of prototype systems in selected hospitals for on-site testing prior to commercial launch.

Expertise Areas

  • Point-of-care / near-patient sequencing diagnostics
  • Infectious disease and antimicrobial resistance diagnostics
  • Bloodstream infection (sepsis) diagnostics
  • NGS assay development
  • Show More (6)

Key Technologies

  • Semiconductor (chip-based) sequencing
  • Next-generation sequencing (NGS)
  • Cartridge-based automated sample-to-result workflows
  • Lab-on-a-chip / microfluidics
  • Show More (4)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.